Ozempic, Wegovy, Mounjaro: Altered Taste Perception

Summary of Research on Ozempic, Wegovy, and Mounjaro & Taste Perception

Here’s a summary of teh research presented at the⁣ European Association for the Study of Diabetes (EASD) meeting:

Key Findings:

* Altered Taste Perception: Approximately one in five individuals taking Ozempic, Wegovy, or ⁣mounjaro reported that foods tasted sweeter or saltier than before starting ‍treatment. Bitterness and sourness perception remained unchanged.
* Wegovy & Saltiness: A higher percentage of wegovy users (26.7%) reported increased saltiness perception compared to Ozempic (16.2%) and mounjaro (15.2%) users.
* Appetite & Satiety Changes: A important majority of participants experienced:
* Decreased Appetite: Over 58% reported feeling less hungry.
⁤ ⁢* Increased Satiety: ⁣Over 63% felt fuller sooner.
* Reduced Cravings: Mounjaro users reported the strongest reduction in‍ food cravings (41.3%), followed by Wegovy (34.1%) and Ozempic (29.7%).
* Link to Weight Loss: changes ‍in taste perception were linked to a reduction in appetite.
* Weight Loss Results: Participants experienced significant BMI⁤ reductions:
⁤* Ozempic: 17.4%
⁤ * Wegovy: 17.6%
* Mounjaro: 15.5%

Study Details:

* Participants: 411 ⁣individuals with overweight or ‍obesity taking Ozempic, Wegovy, or Mounjaro for weight loss.
* Treatment Duration: Average of 40-47 weeks.
* Methodology: Online survey assessing taste perception, appetite, satiety, cravings, and lifestyle factors.

Implications:

The researchers suggest that these changes in taste perception could be a contributing factor to appetite control and weight ⁢loss. Understanding this connection could help clinicians personalize treatment plans and provide more effective dietary⁣ advice for patients using‍ these medications.